go to topGene Engineering Division > Depositors List >
Kotaro Sugimoto's web page in English / in Japanese
Learn more about their research in ORCID
| Catalog # | Name of clone | Running title | Publication |
| RDB21029 | pCSII-LAT1-HA | Expression vector of human L-Type Amino Acid Transporter 1 (LAT1: SLC7A5). Compatible with lentiviral transduction (3rd generation). | Onagi, A., Extrajunctional CLDN10 cooperates with LAT1 and accelerates clear cell renal cell carcinoma progression. Cell Commun. Signal 22 (1): 588 (2024). PMID 39639312. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21028 | pCSII-CLDN16 | Expression vector of human claudin-16 (CLDN16). Compatible with lentiviral transduction (3rd generation). | Onagi, A., Extrajunctional CLDN10 cooperates with LAT1 and accelerates clear cell renal cell carcinoma progression. Cell Commun. Signal 22 (1): 588 (2024). PMID 39639312. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21027 | pCSII-CLDN15 | Expression vector of human claudin-15 (CLDN15). Compatible with lentiviral transduction (3rd generation). | Rahman, A., Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer. Int. J. Mol. Sci. 22 (7): 3774 (2021). PMID 33917356. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21026 | pCSII-CLDN12 | Expression vector of human claudin-12 (CLDN12). Compatible with lentiviral transduction (3rd generation). | Rahman, A., Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer. Int. J. Mol. Sci. 22 (7): 3774 (2021). PMID 33917356. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21025 | pCSII-CLDN11 | Expression vector of human claudin-11 (CLDN11). Compatible with lentiviral transduction (3rd generation). | Onagi, A., Extrajunctional CLDN10 cooperates with LAT1 and accelerates clear cell renal cell carcinoma progression. Cell Commun. Signal 22 (1): 588 (2024). PMID 39639312. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21024 | pCSII-CLDN10B | Expression vector of human claudin-10B (CLDN10B). Compatible with lentiviral transduction (3rd generation). | Onagi, A., Extrajunctional CLDN10 cooperates with LAT1 and accelerates clear cell renal cell carcinoma progression. Cell Commun. Signal 22 (1): 588 (2024). PMID 39639312. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21023 | pCSII-CLDN10A | Expression vector of human claudin-10A (CLDN10A). Compatible with lentiviral transduction (3rd generation). | Rahman, A., Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer. Int. J. Mol. Sci. 22 (7): 3774 (2021). PMID 33917356. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21022 | pCSII-CLDN9 | Expression vector of human claudin-9 (CLDN9). Compatible with lentiviral transduction (3rd generation). | Kojima, M., Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers (Basel) 12 (10): 2748 (2020). PMID 32987797. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21021 | pCSII-CLDN8 | Expression vector of human claudin-8 (CLDN8). Compatible with lentiviral transduction (3rd generation). | Onagi, A., Extrajunctional CLDN10 cooperates with LAT1 and accelerates clear cell renal cell carcinoma progression. Cell Commun. Signal 22 (1): 588 (2024). PMID 39639312. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21020 | pCSII-CLDN7 | Expression vector of human claudin-7 (CLDN7). Compatible with lentiviral transduction (3rd generation). | Onagi, A., Extrajunctional CLDN10 cooperates with LAT1 and accelerates clear cell renal cell carcinoma progression. Cell Commun. Signal 22 (1): 588 (2024). PMID 39639312. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21019 | pCSII-CLDN6 | Expression vector of human claudin-6 (CLDN6). Compatible with lentiviral transduction (3rd generation). | Kojima, M., Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers (Basel) 12 (10): 2748 (2020). PMID 32987797. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21018 | pCSII-CLDN5 | Expression vector of human claudin-5 (CLDN5). Compatible with lentiviral transduction (3rd generation). | Rahman, A., Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer. Int. J. Mol. Sci. 22 (7): 3774 (2021). PMID 33917356. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21017 | pCSII-CLDN4 | Expression vector of human claudin-4 (CLDN4). Compatible with lentiviral transduction (3rd generation). | Kojima, M., Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers (Basel) 12 (10): 2748 (2020). PMID 32987797. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21016 | pCSII-CLDN3 | Expression vector of human claudin-3 (CLDN3). Compatible with lentiviral transduction (3rd generation). | Rahman, A., Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer. Int. J. Mol. Sci. 22 (7): 3774 (2021). PMID 33917356. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21015 | pCSII-CLDN2 | Expression vector of human claudin-2 (CLDN2). Compatible with lentiviral transduction (3rd generation). | Onagi, A., Extrajunctional CLDN10 cooperates with LAT1 and accelerates clear cell renal cell carcinoma progression. Cell Commun. Signal 22 (1): 588 (2024). PMID 39639312. [PubMed] [Article] [RRC of NBRP] (original) |
| RDB21014 | pCSII-CLDN1 | Expression vector of human claudin-1 (CLDN1). Compatible with lentiviral transduction (3rd generation). | Kojima, M., Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers (Basel) 12 (10): 2748 (2020). PMID 32987797. [PubMed] [Article] [RRC of NBRP] (original) |
2025.11.19
depxxxx_html_4_250330.pl